- COVID-19 Vaccine Developers Search for Antibodies That ‘First Do No Harm’
An article in Scientific American describing how biotechs and pharma are trying to protect patients without triggering immune system havoc
- Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
A major challenge during rapid development of COVID-19 vaccines is to avoid safety issues both by thoughtful vaccine design and by thorough evaluation in a timely manner. This report summarizes the evidence presented and provides considerations for safety assessment of COVID-19 vaccine candidates in accelerated vaccine development.